...
indp-img

Indaptus Therapeutics Inc, Common Stock

INDP

NAQ

$0.9116

+$0

(0%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$10.92M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
22.48K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.13
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.84 L
$3.1 H
$0.9116

About Indaptus Therapeutics Inc, Common Stock

Indaptus Therapeutics, Inc., a clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate is Decoy20 used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, which is in Phase 2 clinical trial. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is headquartered in New York, New York. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameINDPSectorS&P500
1-Week Return-6.98%-2.06%-0.55%
1-Month Return-17.13%-1.92%2.72%
3-Month Return-35.35%-10.4%7.66%
6-Month Return-63.39%-4.6%10.15%
1-Year Return-51.25%4.06%27.53%
3-Year Return-83.75%1.94%32.31%
5-Year Return-97.63%36.48%89.2%
10-Year Return-99.81%97.46%194.59%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue854.00K852.001.40K1.78K1.28K[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":0.1,"profit":true},{"date":"2021-12-31","value":0.16,"profit":true},{"date":"2022-12-31","value":0.21,"profit":true},{"date":"2023-12-31","value":0.15,"profit":true}]
Gross Profit(854.00K)(852.00)(1.40K)(1.78K)(1.28K)[{"date":"2019-12-31","value":-85400000,"profit":false},{"date":"2020-12-31","value":-85200,"profit":false},{"date":"2021-12-31","value":-140300,"profit":false},{"date":"2022-12-31","value":-178100,"profit":false},{"date":"2023-12-31","value":-128400,"profit":false}]
Gross Margin-(Infinity%)(Infinity%)(Infinity%)(Infinity%)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Operating Expenses34.09M3.60M7.73M14.91M16.38M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":10.56,"profit":true},{"date":"2021-12-31","value":22.67,"profit":true},{"date":"2022-12-31","value":43.74,"profit":true},{"date":"2023-12-31","value":48.04,"profit":true}]
Operating Income(34.95M)(3.60M)(7.73M)(14.91M)(16.38M)[{"date":"2019-12-31","value":-3494600000,"profit":false},{"date":"2020-12-31","value":-359926500,"profit":false},{"date":"2021-12-31","value":-772910800,"profit":false},{"date":"2022-12-31","value":-1491090600,"profit":false},{"date":"2023-12-31","value":-1637847400,"profit":false}]
Total Non-Operating Income/Expense-30.23K35.44K1.18M-[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":2.57,"profit":true},{"date":"2021-12-31","value":3.01,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Pre-Tax Income(46.96M)(3.58M)(7.71M)(14.32M)(15.42M)[{"date":"2019-12-31","value":-4696100000,"profit":false},{"date":"2020-12-31","value":-358415100,"profit":false},{"date":"2021-12-31","value":-771138600,"profit":false},{"date":"2022-12-31","value":-1432279800,"profit":false},{"date":"2023-12-31","value":-1542347100,"profit":false}]
Income Taxes638.00K(15.11K)(17.72K)(588.11K)(16.38M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-2.37,"profit":false},{"date":"2021-12-31","value":-2.78,"profit":false},{"date":"2022-12-31","value":-92.18,"profit":false},{"date":"2023-12-31","value":-2567.36,"profit":false}]
Income After Taxes-(3.57M)(7.69M)(13.73M)-[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-356903700,"profit":false},{"date":"2021-12-31","value":-769366400,"profit":false},{"date":"2022-12-31","value":-1373469000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations-(3.58M)(7.71M)(14.32M)(15.08M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-358415100,"profit":false},{"date":"2021-12-31","value":-771138600,"profit":false},{"date":"2022-12-31","value":-1432279800,"profit":false},{"date":"2023-12-31","value":-1507646800,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(47.60M)(3.57M)(7.69M)(13.73M)(15.42M)[{"date":"2019-12-31","value":-4759900000,"profit":false},{"date":"2020-12-31","value":-356903700,"profit":false},{"date":"2021-12-31","value":-769366400,"profit":false},{"date":"2022-12-31","value":-1373469000,"profit":false},{"date":"2023-12-31","value":-1542347100,"profit":false}]
EPS (Diluted)(89.60)(16.32)(10.40)(1.73)(1.85)[{"date":"2019-12-31","value":-8960,"profit":false},{"date":"2020-12-31","value":-1632,"profit":false},{"date":"2021-12-31","value":-1040,"profit":false},{"date":"2022-12-31","value":-173,"profit":false},{"date":"2023-12-31","value":-185,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

INDP
Cash Ratio 3.31
Current Ratio 3.42

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

INDP
ROA (LTM) -71.12%
ROE (LTM) -127.04%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

INDP
Debt Ratio Lower is generally better. Negative is bad. 0.27
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.73

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

INDP
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 1.82
Price/FCF NM
EV/R 0.00
EV/Ebitda 1.03

FAQs

What is Indaptus Therapeutics Inc share price today?

Indaptus Therapeutics Inc (INDP) share price today is $0.9116

Can Indians buy Indaptus Therapeutics Inc shares?

Yes, Indians can buy shares of Indaptus Therapeutics Inc (INDP) on Vested. To buy Indaptus Therapeutics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in INDP stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Indaptus Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Indaptus Therapeutics Inc (INDP) via the Vested app. You can start investing in Indaptus Therapeutics Inc (INDP) with a minimum investment of $1.

How to invest in Indaptus Therapeutics Inc shares from India?

You can invest in shares of Indaptus Therapeutics Inc (INDP) via Vested in three simple steps:

  • Click on Sign Up or Invest in INDP stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Indaptus Therapeutics Inc shares
What is Indaptus Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Indaptus Therapeutics Inc (INDP) is $3.1. The 52-week low price of Indaptus Therapeutics Inc (INDP) is $0.84.

What is Indaptus Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Indaptus Therapeutics Inc (INDP) is

What is Indaptus Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Indaptus Therapeutics Inc (INDP) is 1.82

What is Indaptus Therapeutics Inc dividend yield?

The dividend yield of Indaptus Therapeutics Inc (INDP) is 0.00%

What is the Market Cap of Indaptus Therapeutics Inc?

The market capitalization of Indaptus Therapeutics Inc (INDP) is $10.92M

What is Indaptus Therapeutics Inc’s stock symbol?

The stock symbol (or ticker) of Indaptus Therapeutics Inc is INDP

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top